Literature DB >> 21314663

Guideline-driven polypharmacy in elderly, multimorbid patients is basically flawed: there are almost no guidelines for these patients.

Martin Wehling.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21314663     DOI： 10.1111/j.1532-5415.2011.03252.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  14 in total

Review 1.  Evidence-based strategies for the optimization of pharmacotherapy in older people.

Authors:  Eva Topinková; Jean Pierre Baeyens; Jean-Pierre Michel; Pierre-Olivier Lang
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

2.  Higher Fit-fOR-The-Aged (FORTA) Scores Comprising Medication Errors are Associated with Impaired Cognitive and Physical Function Tests in the VALFORTA Trial.

Authors:  Farhad Pazan; Heinrich Burkhardt; Helmut Frohnhofen; Christel Weiss; Christina Throm; Alexandra Kuhn-Thiel; Martin Wehling
Journal:  Drugs Aging       Date:  2019-03       Impact factor: 3.923

Review 3.  [Drug therapy for older people : Choosing wisely].

Authors:  Martin Wehling
Journal:  Z Gerontol Geriatr       Date:  2017-09-22       Impact factor: 1.281

4.  Combined Use of the Rationalization of Home Medication by an Adjusted STOPP in Older Patients (RASP) List and a Pharmacist-Led Medication Review in Very Old Inpatients: Impact on Quality of Prescribing and Clinical Outcome.

Authors:  Lorenz Van der Linden; Liesbeth Decoutere; Karolien Walgraeve; Koen Milisen; Johan Flamaing; Isabel Spriet; Jos Tournoy
Journal:  Drugs Aging       Date:  2017-02       Impact factor: 3.923

5.  Consensus validation of a screening tool for cardiovascular pharmacotherapy in geriatric patients: the RASP_CARDIO list (Rationalization of Home Medication by an Adjusted STOPP list in Older Patients).

Authors:  Hannah De Schutter; Julie Hias; Laura Hellemans; Karolien Walgraeve; Jos Tournoy; Peter Verhamme; Peter Sinnaeve; Rik Willems; Walter Droogné; Christophe Vandenbriele; Lucas Van Aelst; Thomas Vanassche; Lorenz Van der Linden
Journal:  Eur Geriatr Med       Date:  2022-10-14       Impact factor: 3.269

Review 6.  A systematic review and novel classification of listing tools to improve medication in older people.

Authors:  Farhad Pazan; Jonathan Kather; Martin Wehling
Journal:  Eur J Clin Pharmacol       Date:  2019-01-26       Impact factor: 2.953

7.  The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People.

Authors:  Farhad Pazan; Christel Weiss; Martin Wehling
Journal:  Drugs Aging       Date:  2018-01       Impact factor: 3.923

8.  [Medication in the elderly : cognitive impairment by drugs].

Authors:  M Wehling
Journal:  Internist (Berl)       Date:  2012-10       Impact factor: 0.743

9.  What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process.

Authors:  Barbara Farrell; Corey Tsang; Lalitha Raman-Wilms; Hannah Irving; James Conklin; Kevin Pottie
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

10.  Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly.

Authors:  Alexandra M Kuhn-Thiel; Christel Weiß; Martin Wehling
Journal:  Drugs Aging       Date:  2014-02       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.